2205032-89-7

2205032-89-7 structure

Name: ML211
Chemical Name: ML-211
CAS Number: 2205032-89-7
Molecular Formula: C₂₅H₃₀N₄O₂
Molecular Weight: 418.531
Catalog: Signaling Pathways Metabolic Enzyme/Protease MAGL
Create Date: 2021-09-11 19:23:59
Modify Date: 2025-08-25 13:32:15
ML-211 is a carbamate-based dual inhibitor of acyl-protein thioesterase 1 (APT1)/lysophospholipase 1 (LYPLA1) (IC50=17 nM) and LYPLA2 (IC50=30 nM). ML-211 also inhibits theserine hydrolase ABHD11 with an IC50 value of 10 nM but is ≥ 50-fold selective for LYPLA in a panel of 20 additional serine hydrolases[1].

Name	ML-211
Synonyms	{4-[Hydroxy(diphenyl)methyl]-2H-1,2,3-triazol-2-yl}[4-(2-methyl-2-propanyl)-1-piperidinyl]methanone Methanone, [4-(1,1-dimethylethyl)-1-piperidinyl][4-(hydroxydiphenylmethyl)-2H-1,2,3-triazol-2-yl]- ML-211

Description	ML-211 is a carbamate-based dual inhibitor of acyl-protein thioesterase 1 (APT1)/lysophospholipase 1 (LYPLA1) (IC50=17 nM) and LYPLA2 (IC50=30 nM). ML-211 also inhibits theserine hydrolase ABHD11 with an IC50 value of 10 nM but is ≥ 50-fold selective for LYPLA in a panel of 20 additional serine hydrolases[1].
Related Catalog	Signaling Pathways >> Metabolic Enzyme/Protease >> Phospholipase Signaling Pathways >> Metabolic Enzyme/Protease >> MAGL
References	[1]. Adibekian, A., Martin, B.R., Speers, A.E., et al. Optimization and characterization of a triazole urea dual inhibitor for lysophospholipase 1 (LYPLA1) and lysophospholipase 2 (LYPLA2). Probe Reports from the NIH Molecular Libraries Program 1 R01 CA132630, 1-42 (2013).